3Koreck A, Suranyi A, Szony BJ, et al. CD3: CD56: NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol, 2002, 127: 176-182.
4Chan WL, Pejnovic N, Liew TV, et al. NKT cell subsets in infection and inflammation. Immunol Lett, 2003, 85: 159-163.
5Curry JL, Qin JZ, Bonish B, et al. Innate immune-related receptors in normal and psoriatic skin.Arch Pathol Lab Med, 2003, 127:178-186.
6Siegel I, Liu TL, Gleicher N. The red-cell immune system. Lancet,1981, 2: 556-559.
7Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol, 2004, 150: 232-244.
8Gornicki A, Gutsze A. .Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci, 2001, 27: 27-30.
9Triolo G, Accardo-Palumbo A, Salli L, et al. Impaired expression of erythrocyte glycosyl -phosphatidylinositol -anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation. Clin Exp Rheumatol, 2003, 21: 225-228.
10Ozturk G, Erbas D, Gelir E, e~t al. Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with ps6riasis vulgaris. Immunol Invest, 2001, 30: 181-190.
